secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aura Biosciences, Inc. (AURA)
CIK:        0001501796
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0001193125-26-204049
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Aura Biosciences to repurchase ~6.9M shares from Matrix Capital at $5.64; reports preliminary cash of $114.7M
--------------------------------------------------------------------------------

- Enters stock purchase agreement to repurchase up to 6,922,870 shares from Matrix Capital Master Fund at $5.64 per share, matching equity offering price.
- Repurchase conditioned on closing of equity offering; expected after offering closing. Matrix held 10.8% of outstanding shares pre-transaction.
- Preliminary cash, cash equivalents, and marketable securities as of March 31, 2026: approximately $114.7 million (unaudited).
- Repurchase funded by net proceeds from equity offering exceeding $200M; shares become authorized but unissued.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501796/000119312526204049/0001193125-26-204049-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501796/000119312526204049/d38347d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-204049

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer